KYORIN Pharmaceutical Co., Ltd.
【Kyorin Pharmaceutical】Executive Changes and Organizational Reinforcement｜May 2026
Kyorin Pharmaceutical conducted executive personnel changes on June 19, 2026. They appointed Mr. Tomohiro Okadaniya, an attorney, as a new Outside Director candidate, and announced the impending resignation of some officers.
Key Figures
- New Outside Director Candidate: Mr. Tomohiro Okadaniya (born October 28, 1957)
- Resigning officers: Mr. Doro Oonoda, Mr. Noriyuki Kanai
- Scheduled change date: June 19, 2026
AI要約
Overview of Executive Changes
Kyorin Pharmaceutical will implement executive personnel changes at the Ordinary General Meeting of Shareholders scheduled for June 19, 2026. They are appointing Mr. Tomohiro Okadaniya, an attorney, as an Outside Director candidate, and Mr. Norifumi Tamura, Managing Executive Officer, is scheduled to assume the role of Director. Resigning officers include Mr. Doro Oonoda and Mr. Noriyuki Kanai. This move aims to strengthen legal expertise and enhance corporate governance.
Future Corporate Activities and Strategies
The personnel refreshment aims to strengthen corporate governance and promote long-term business strategies. The new structure will support the company's development through legal advice and proposals, aiming to improve competitiveness. The resigning officers are expected to continue contributing as advisors, leveraging their experience.
Kyorin Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
